APP下载

左甲状腺素钠联合补硒治疗甲状腺功能减退的效果分析

2020-09-02杨延萍

中外医疗 2020年16期

杨延萍

[摘要] 目的 探讨左甲状腺素钠联合补硒治疗甲状腺功能减退的效果。 方法 对该院2017年2月—2019年3月收治的甲状腺功能减退患者,按标准从中方便选择82例作为该次研究的对象,盲选法随机分为两组,各组病例数一致。对照组患者接受左甲状腺素钠治疗,研究组采用左甲状腺素钠联合补硒治疗。观察与比较两组甲状腺功能指标、血硒水平、血脂检查结果以及不良反应。 结果 治疗后,研究组患者FT3(4.67±0.21)pmol/L、FT4(27.10±5.63)pmol/L、TSH(4.76±6.81)mIU/mL、TG(0.71±0.35)mmol/L、TC(4.53±0.47)mmol/L、HDL-C(1.18±0.07)mmol/L、LDL-C(2.48±0.35)mmol/L均优于对照组的(5.82±0.17)pmol/L、(20.08±5.42)pmol/L、(4.07±6.89)mIU/mL、(1.08±0.32)mmol/L、(5.68±0.39)mmol/L、(1.09±0.04)mmol/L、(3.83±0.29)mmol/L,差异有统计学意义(t=4.031、3.904、3.829、3.892、4.051、3.761、4.228,P<0.05);治疗后研究组血硒水平(124.81±9.67)μg/L明显低于对照组(186.73±11.48)μg/L,差异有统计学意义(t=4.308、P<0.05)。治疗期间,研究组不良反应发生率(7.32%)明显低于对照组(26.83%),差异有统计学意义(χ2=7.061,P<0.05)。結论 对甲状腺功能减退患者实施左甲状腺素钠联合补硒治疗能够有效改善患者甲状腺功能与血脂情况,提升患者体内血硒浓度,治疗安全性更高。

[关键词] 甲状腺功能减退;左甲状腺素钠;补硒治疗

[中图分类号] R581          [文献标识码] A          [文章编号] 1674-0742(2020)06(a)-0109-03

Effect of Levothyroxine Sodium Combined with Selenium Supplementation on Hypothyroidism

YANG Yan-ping

Department of Endocrinology, the People's Hospital of Linyi County,Linyi,Shandong Province,251500 China

[Abstract] Objective To investigate the effect of levothyroxine sodium combined with selenium supplementation on hypothyroidism. Methods For the patients with hypothyroidism treated in the hospital from February 2017 to March 2019, 82 patients were convenient selected as the object of this study according to the standard. The blind selection method was randomly divided into two groups with the same number of cases in each group. Patients in the control group received levothyroxine sodium treatment, while study group received levothyroxine sodium plus selenium supplementation. Observe and compare the thyroid function indexes, blood selenium levels, blood lipid test results, and adverse reactions in the two groups. Results After treatment, patients in the study group hadFT3(4.67±0.21)pmol/L、FT4(27.10±5.63)pmol/L、TSH(4.76±6.81)mIU/mL、TG(0.71±0.35)mmol/L、TC(4.53±0.47)mmol/L、HDL-C(1.18±0.07)mmol/L、LDL-C(2.48±0.35)mmol/L, were better than the control group of (5.82±0.17)pmol/L、(20.08±5.42)pmol/L、(4.07±6.89)mIU/mL、(1.08±0.32)mmol/L、(5.68±0.39)mmol/L、(1.09±0.04)mmol/L、(3.83±0.29)mmol/L, and the differences were statistically significant (t=4.031, 3.904, 3.829, 3.892, 3.892, 4.051, 3.761, 4.228, P<0.05); blood selenium levels in the study group (124.81±9.67)μg/L were significantly lower than those in the control group (186.73±11.48)μg/L after treatment, with statistical differences(t=4.308, P<0.05). During the treatment period, the incidence of adverse reactions (7.32%) in the study group was significantly lower than that in the control group (26.83%), which was statistically significantly different(χ2=7.061, P<0.05). Conclusion Levothyroxine sodium combined with selenium supplementation in patients with hypothyroidism can effectively improve the thyroid function and blood lipids of patients, increase the blood selenium concentration in patients, and make the treatment safer.

[Key words] Hypothyroidism; Levothyroxine sodium; Selenium supplementation

甲状腺功能减退是一种较为常见的内分泌疾病,妇女老年群体是易患人群。临床上将甲状腺功能减退分为原发性、继发性以及周围性三类,其中原发性甲状腺功能减退最为常见,在三类患者中占比约91%[1]。甲状腺功能减退,目前尚无特效治疗方法,需要终身代替治疗,临床常使用左甲状腺素钠治疗,但患者长期服药容易出现甲状腺功能亢进等病症,进一步影响了患者的生活质量[2]。因此寻找更为有效与安全的疗法对于改善甲状腺功能减退患者预后具有重要的意义。该文选择该院2017年2月—2019年3月收治的82例甲状腺功能减退患者作为研究对象,盲选法随机分为两组,各组(对照组、研究组)病例数一致(41例),分析左甲状腺素钠联合补硒治疗的效果,现报道如下。

1  资料与方法

1.1  一般资料

对该院收治的甲状腺功能减退患者,按标准从中选择82例作为该次研究的对象,盲选法随机分为两组,各组病例数一致(41例)。……

登录APP查看全文